A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 38/04 (2006.01) C07K 14/435 (2006.01)
Patent
CA 2202513
Novel compounds and compositions for modulating NMDA receptor function comprising Conantokin-G and derivatives thereof; methods for modulating NMDA receptor function and methods for treating neuropsychopharmacological disorders, using the novel compounds and compositions of the invention; and a method for screening compounds capable of binding to a novel allosteric modulatory site, are described.
L'invention se rapporte à de nouveaux composés et compositions destinés à moduler la fonction du récepteur de NMDA et comprenant la Conantokine-G et des dérivés de celle-ci; à des procédés de modulation de la fonction du récepteur de NMDA et à des procédés de traitement des troubles neuropsychopharmacologiques et d'utilisation de ces nouvelles compositions, ainsi qu'à un procédé de criblage de composés capables de se fixer à un nouveau site modulateur allostérique.
Bereskin & Parr
Symphony Pharmaceuticals Inc.
LandOfFree
Allosteric modulators of the nmda receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Allosteric modulators of the nmda receptor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Allosteric modulators of the nmda receptor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1663187